Clinical Research Institute of Michigan – Shores Rheumatology
Main: 586-598-3329
Study Coordinator: Amelia Laurence 586-598-3329 X 201
Study Coordinator: Latrece Keaton 586-598-3329 X 202
- Indication: Gout
- Enrollment Status: Open
- Protocol: FYU-981-CRYS-201
- Drug: Dotinurad
- Sponsor: Crystalys
- Description: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad in Adult Participants With Gout who are Intolerant to Xanthine Oxidase Inhibitors or Failed Uricase Treatment